<HashMap><database>GEO</database><scores/><additional><omics_type>Genomics</omics_type><species>Mus musculus</species><gds_type>Non-coding RNA profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328570</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>I-tRF-Asp promotes vascular remodeling in hypoxic pulmonary hypertension via hnRNPU phase separation which affects TCF7L2 alternative splicing.</name><description>BACKGROUND: Pulmonary hypertension (PH) is a fatal disease characterized by pulmonary vascular remodeling, primarily driven by excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs). While non-coding RNAs such as circular RNAs have been implicated in PH, the role of tRNA-derived small RNA (tsRNA) remains poorly understood. Among them, i-tRF-Asp represents a novel tsRNA whose function in hypoxic PH is unknown. This study aims to investigate whether i-tRF-Asp contributes to PASMC proliferation and vascular remodeling in hypoxic PH. METHODS: To elucidate the functional role of i-tRF-Asp, loss-of-function experiments were conducted in vitro using hypoxic mouse PASMCs (mPASMCs), alongside in vivo studies utilizing both SuHx (Sugen5416+hypoxia) induced pulmonary hypertension models in both adult male C57BL/6 mice and Sprague-Dawley rats. These models employed antisense oligonucleotide inhibitor and adeno-associated virus-mediated silencing. The underlying mechanisms were further explored via RNA immunoprecipitation, liquid-liquid phase separation assays, cell proliferation assessment, western blot, alternative splicing profiling and molecular dynamics simulation. RESULTS: Inhibition of i-tRF-Asp ameliorated hypoxia-induced pulmonary vascular remodeling, primarily through suppressing excessive proliferation of mPASMCs. Further analysis indicated that i-tRF-Asp facilitates liquid–liquid phase separation (LLPS) of hnRNPU. This process mediates selective recruitment of Tcf7l2 pre-mRNA and promotes alternative splicing, resulting in a pro-proliferative Tcf7l2 transcript variant that drives mPASMC proliferation. Furthermore, we have identified that the endonuclease ERN1 can upregulate the expression of i-tRF-Asp. CONCLUSION: The endoribonuclease ERN1 upregulates the expression of i-tRF-Asp, which in turn facilitates mPASMC proliferation and pulmonary vascular remodeling. This process is driven by hnRNPU LLPS-dependent alternative splicing of the long Tcf7l2 transcript isoform.</description><dates><publication>2026/06/03</publication></dates><accession>GSE328570</accession><cross_references><GSM>GSM9685476</GSM><GSM>GSM9685475</GSM><GSM>GSM9685474</GSM><GSM>GSM9685473</GSM><GSM>GSM9685472</GSM><GSM>GSM9685471</GSM><GPL>21626</GPL><GSE>328570</GSE><taxon>Mus musculus</taxon><PMID>[42206368]</PMID></cross_references></HashMap>